On 20 January, Halliburton Company (NYSE:HAL) posted higher earnings and revenue in its December quarter. For the quarter ended Dec. 31, Halliburton reported a profit of $901 million, or $1.06 a share, compared with a year-earlier profit of $793 million, or 93 cents a share. Halliburton said it took a $129 million restructuring charge in the quarter to temper the weak outlook. Excluding that and a $19 million charge related to the Baker Hughes acquisition, earnings were $1.19 a share. On Wednesday shares of Halliburton Company (NYSE:HAL) closed at $42.39. Company’s sales growth for last 5 years was 17.50% and EPS growth for next 5 years is recorded as 10.68%.
On 3 February, Banco Santander, S.A. (NYSE:SAN) reported quarterly net profit surged to EUR1.46 billion ($1.65 billion), versus a restated EUR864 million, in the year-ago period. Earnings per share rose to 0.112 euro from 0.076 euro. However, analysts were expecting a profit of EUR1.45 billion. Banco Santander, S.A. (NYSE:SAN) in last trading activity decreased -2.52% to close at $6.96. Company weekly performance is 5.14% while its quarterly performance stands at -17.83%. Banco Santander, S.A. (NYSE:SAN) is -30.85% away from its 52 week high.
Linn Co, LLC (NASDAQ:LNCO) was downgraded by equities research analysts at Howard Weil to a “sector perform” rating in a research note issued to investors on Tuesday. On last trading day Linn Co, LLC (NASDAQ:LNCO) decreased -2.79% to close at $11.86. Its volatility for the week is 7.54% while volatility for the month is 6.94%. Linn Co, LLC (NASDAQ:LNCO) monthly performance is 6.75%.
On 30 January, Celldex Therapeutics, Inc. (NASDAQ:CLDX) and Bristol-Myers Squibb Company announced the commencement of a phase I/II dose escalation and cohort expansion study to evaluate Celldex’s varlilumab (a monoclonal investigational antibody targeting CD27) in combination with Bristol-Myers’ Opdivo (human programmed death receptor-1 blocking antibody). Celldex Therapeutics, Inc. (NASDAQ:CLDX) has 0.28% insider ownership while its institutional ownership stands at 91.10%. In last trading activity company’s stock closed at $19.12.
NRG Energy, Inc. (NYSE:NRG) announced a cash dividend. Payment of $0.145 per share is scheduled to be paid on February 17, 2015. Shareholders who purchased NRG stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 3.57% increase over the prior quarter. On last trading day NRG Energy, Inc. (NYSE:NRG) remains unchanged to close at $26.04. Its volatility for the week is 3.85% while volatility for the month is 3.25%. NRG’s sales growth for past 5 years was 10.40% and its EPS growth for past 5 years was -18.30%. NRG Energy, Inc. (NYSE:NRG) monthly performance is -0.95%.